These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19133578)

  • 21. Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration.
    Chappell D; Bruchelt W; Schenk W; Jacob M; Hofmann-Kiefer K; Conzen P; Kreimeier U; Rehm M
    J Pediatr; 2008 Oct; 153(4):579-81. PubMed ID: 18847623
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucose control in critically ill patients.
    Braithwaite SS
    N Engl J Med; 2009 Jul; 361(1):89-90; author reply 91-2. PubMed ID: 19579271
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute kidney injury by hydroxyethyl starch: Can the risks be mitigated?
    Davidson IJ
    Crit Care Med; 2009 Apr; 37(4):1499-501. PubMed ID: 19318837
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit.
    Gibson BR; Galiatsatos P; Rabiee A; Eaton L; Abu-Hamdah R; Christmas C; Milner SM; Andersen DK; Elahi D
    Surgery; 2009 Nov; 146(5):922-30. PubMed ID: 19733884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of different replacement fluids during extracorporeal treatment in a pig model of sepsis.
    Sauer M; Altrichter J; Mencke T; Klöhr S; Thomsen M; Kreutzer HJ; Nöldge-Schomburg G; Mitzner SR
    Ther Apher Dial; 2013 Feb; 17(1):84-92. PubMed ID: 23379499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin therapy on intensive care should not be too intensive].
    Girbes AR; Beishuizen A
    Ned Tijdschr Geneeskd; 2009; 153():A609. PubMed ID: 19785880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyethyl starch 130/0.4: does "modern" mean safe?
    Wiedermann CJ
    Anesth Analg; 2009 Oct; 109(4):1346-7; author reply 1347. PubMed ID: 19762769
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood sugar regulation in critically ill patients].
    Toft P
    Ugeskr Laeger; 2006 Apr; 168(17):1661. PubMed ID: 16674880
    [No Abstract]   [Full Text] [Related]  

  • 32. Is there a role for intensive insulin therapy in patients with kidney disease?
    Ritchie-McLean S; Kirwan C; Levy JB
    Am J Kidney Dis; 2007 Sep; 50(3):371-8. PubMed ID: 17720516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Albumin or physiologic saline to hypovolemic intensive care patients?].
    Gøtzsche PC; Møller AM; Pedersen T
    Ugeskr Laeger; 2004 Oct; 166(43):3835. PubMed ID: 15544121
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use and misuse of albumin].
    Laake JH
    Tidsskr Nor Laegeforen; 2005 Dec; 125(24):3430-2. PubMed ID: 16357884
    [No Abstract]   [Full Text] [Related]  

  • 35. Limited Dosage for HES?
    Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S102-3. PubMed ID: 11753710
    [No Abstract]   [Full Text] [Related]  

  • 36. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.
    Haskell LP; Tannenberg AM
    N Y State J Med; 1988 Jul; 88(7):387-8. PubMed ID: 2457189
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoglycemia and strict glycemic control in critically ill patients.
    Vriesendorp TM; DeVries JH; Hoekstra JB
    Curr Opin Crit Care; 2008 Aug; 14(4):397-402. PubMed ID: 18614902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Saline versus Albumin Fluid Evaluation (SAFE) study. Albumin does not increase the mortality of intensive care patients. A study with many aspects].
    Larsson A
    Ugeskr Laeger; 2004 Oct; 166(43):3836-7. PubMed ID: 15544122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Early goal-directed life-saving therapy of sepsis].
    Larsson A; Tønnesen E
    Ugeskr Laeger; 2002 Jan; 164(5):646. PubMed ID: 11871220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.